Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205270 · ClinicalTrials.gov registry record
Influenza Vaccine in Lung Transplant Patients
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 126
- Enrollment target
NCT00205270 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 126 participants.
The verdict
NCT00205270 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This 5-year study was designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals.
Interventions
- DRUG Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00205270
The ClinicalTrials.gov registry entry for NCT00205270 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Influenza vaccine is the first listed.
NCT00205270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00205270 about?
NCT00205270 is a clinical study titled "Influenza Vaccine in Lung Transplant Patients". This 5-year study was designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals.
What is the current status of trial NCT00205270?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2004-12. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00205270?
The interventions under investigation include: Influenza vaccine (DRUG).
Who is sponsoring clinical trial NCT00205270?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.